Neurology and Neurosurgery

1-8 of 8

• 

  RestartResume

  EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions

  RestartResume

  EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions

  MinuteCE®

  EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions

  Benjamin Levy, MD; Melin Khandekar, MD, PhD

  1.00 program credit

  • 

    

    Benjamin Levy, MD

  • 

    

    Melin Khandekar, MD, PhD

  1.00 program credit

• 

  RestartResume

  Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 

  RestartResume

  Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 

  MinuteCE®

  Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 

  Benjamin Levy, MD; Melin Khandekar, MD, PhD

  1.00 program credit

  • 

    

    Benjamin Levy, MD

  • 

    

    Melin Khandekar, MD, PhD

  1.00 program credit

• 

  RestartResume

  Brain Metastases Management: From Detection to Multidisciplinary Care

  RestartResume

  Brain Metastases Management: From Detection to Multidisciplinary Care

  MinuteCE®

  Brain Metastases Management: From Detection to Multidisciplinary Care

  Barbara O'Brien, MD

  1.00 program credit

  • 

    

    Barbara O'Brien, MD

  1.00 program credit

• 

  RestartResume

  HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era

  RestartResume

  HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era

  MinuteCE®

  HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era

  Barbara O'Brien, MD; Nadia Harbeck, MD, PhD

  1.00 program credit

  • 

    

    Barbara O'Brien, MD

  • 

    

    Nadia Harbeck, MD, PhD

  1.00 program credit

• 

  RestartResume

  Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases

  RestartResume

  Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases

  CME/CE

  Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases

  Barbara O'Brien, MD

  0.25 credits

  • 

    

    Barbara O'Brien, MD

  0.25 credits

• 

  RestartResume

  Managing Brain Metastases Through Multidisciplinary Team Collaboration

  RestartResume

  Managing Brain Metastases Through Multidisciplinary Team Collaboration

  MinuteCE®

  Managing Brain Metastases Through Multidisciplinary Team Collaboration

  Benjamin Levy, MD

  1.00 program credit

  • 

    

    Benjamin Levy, MD

  1.00 program credit

• 

  RestartResume

  First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases

  RestartResume

  First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases

  MinuteCE®

  First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases

  Barbara O'Brien, MD; Nadia Harbeck, MD, PhD

  1.00 program credit

  • 

    

    Barbara O'Brien, MD

  • 

    

    Nadia Harbeck, MD, PhD

  1.00 program credit

• 

  MinuteCE®

  Inside the Decision: Case-Based Navigation of Brain Metastases in Breast and Lung Cancer

  Barbara O'Brien, MD; Benjamin Levy, MD

  1.00 credit 6 episodes

  • 

    

    Barbara O'Brien, MD

  • 

    

    Benjamin Levy, MD

  • 

    

    Melin Khandekar, MD, PhD

  • 

    

    Nadia Harbeck, MD, PhD

  1.00 credit 6 episodes